Literature DB >> 11791388

[A case of advanced gastric cancer producing alpha fetoprotein with multiple liver metastases responding to TS-1 after TAE].

M Okazaki1, J Yamamura, Y Kawasaki, M Ohtsuru, K Kobayakawa, S Yasuda, H Oka, M Yamamura, Y Hayashi.   

Abstract

We report a case of advanced gastric cancer producing Alpha Fetoprotein (AFP) with multiple liver metastases in which TS-1 is effective. Prognosis of gastric cancer producing AFP is well known to poor. A 74-year-old female was admitted complaining of anemia. She was diagnosed as having advanced gastric cancer with multiple liver metastases producing AFP by endoscopy, computed tomography and angiography. Her serum AFP level was 17,666 ng/ml and her serum CEA level was 5-2 ng/ml. After transarterial embolization (TAE), her family rejected her operation because it would not be curative. So, she was treated with TS-1, 40 mg, administered orally every day, followed by 14 days rest, as the first course. The next was TS-1, 80 mg orally administered for 6 courses. Her serum AFP level was down from 17,666 ng/ml to 94 ng/ml after 6 courses of TS-1. CT revealed that liver metastases did not change and endoscopy showed the primary lesion has diminished. Our report is the first to demonstrate that TS-1 is effective for patients with advanced gastric cancer producing AFP with multiple liver metastases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11791388

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer.

Authors:  Yoshihisa Takahashi; Tohru Inoue; Toshio Fukusato
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

2.  Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.

Authors:  Yutaka Shibata; Kouhei Sato; Masashi Kodama; Hiroshi Nanjyo
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.